Call Me Free
Home ›› Products ›› API ›› Anastrazole API
Previous Product Next Product
Anastrazole API

Anastrazole API

Anastrozole API, a potent aromatase inhibitor, is pivotal in the treatment of hormone receptor-positive breast cancer. By selectively inhibiting aromatase enzyme activity, it suppresses estrogen synthesis, thus depriving estrogen-dependent tumors of their growth stimulus. Anastrozole API is widely recognized for its efficacy in postmenopausal women, offering superior outcomes in hormone therapy. Formulated by various manufacturers, it ensures widespread availability for cancer treatment regimens. Trusted by healthcare professionals globally, Anastrozole API stands as a cornerstone in breast cancer management, providing hope and improved quality of life for patients. Consultation with healthcare providers is advised for personalized treatment plans tailored to individual medical conditions.
Inquiry Now

Manufacturing Unit-I

Block/Survey No. 497, Mauhuvej, nr. Fairdeal Textile Park, Kosamba, Gujarat 394125, India